3'-epi-12β-hydroxyfroside induces autophagic degradation of ABCG2 to overcome drug resistance in lung cancer cells
Open Access
- 22 April 2025
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 187, 118085
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32460190)
- Hainan Province Natural Science Foundation (ZDKJ202003)
This publication has 42 references indexed in Scilit:
- BAG family proteins contributes to autophagy-mediated multidrug resistance of tumorClinical and Translational Oncology, 2022
- MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo studyActa Pharmaceutica Sinica B, 2021
- Engineered porous/hollow Burkholderia pseudomallei loading tumor lysate as a vaccineBiomaterials, 2021
- Multidrug efflux transporter ABCG2: expression and regulationCellular and Molecular Life Sciences, 2021
- Emerging role of autophagy in anti-tumor immunity: Implications for the modulation of immunotherapy resistanceDrug Resistance Updates, 2021
- Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2Drug Metabolism and Pharmacokinetics, 2018
- Plant-derived cardiac glycosides: Role in heart ailments and cancer managementBiomedicine & Pharmacotherapy, 2016
- ABC transporters as mediators of drug resistance and contributors to cancer cell biologyDrug Resistance Updates, 2016
- BCRP/ABCG2 in the Placenta: Expression, Function and RegulationPharmaceutical Research, 2008
- Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan‐pharmacokinetics and clinical outcome in patients with advanced non‐small cell lung cancerCancer, 2007